Paper10072079
The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases.
Lin X and 4 others. Immunity, 1999. Cited by 166 papers, by iCite.
Cite this record
ConductScience Library. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases. Papers, record 10072079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10072079
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD28 Antigens | Major topic |
| CD3 Complex | Major topic |
| MAP Kinase Kinase Kinases | Major topic |
| NF-kappa B | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Enzyme Induction | |
| Humans | |
| I-kappa B Kinase | |
| Jurkat Cells | |
| Proto-Oncogene Mas | |
| Transcription Factor AP-1 | |
| Transcription, Genetic | |
| NF-kappaB-Inducing Kinase |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08-EY00352 | NEI NIH HHS | United States | K08EY000352 | PubMed and NIH | NIH RePORTER |
| P30A127763 | PHS HHS | United States | PubMed | PubMed |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30482227 | Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D. | J Exp Clin Cancer Res | 2018 | https://conductscience.org/library/papers/30482227 | PubMed |
| 28361341 | Cot kinase plays a critical role in Helicobacter pylori-induced IL-8 expression. | J Microbiol | 2017 | https://conductscience.org/library/papers/28361341 | PubMed |
| 27695399 | NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications. | Front Mol Neurosci | 2016 | https://conductscience.org/library/papers/27695399 | PubMed |
| 27508514 | Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology. | Inflamm Bowel Dis | 2016 | https://conductscience.org/library/papers/27508514 | PubMed |
| 26269411 | Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development. | Sci Rep | 2015 | https://conductscience.org/library/papers/26269411 | PubMed |
| 25723737 | Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/25723737 | PubMed |
| 25674762 | Aberrant expression of COT is related to recurrence of papillary thyroid cancer. | Medicine (Baltimore) | 2015 | https://conductscience.org/library/papers/25674762 | PubMed |
| 25531326 | Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity. | Oncogene | 2015 | https://conductscience.org/library/papers/25531326 | PubMed |
| 25316791 | Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25316791 | PubMed |
| 24996903 | A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function. | Retrovirology | 2014 | https://conductscience.org/library/papers/24996903 | PubMed |
| 24488495 | RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24488495 | PubMed |
| 22988300 | IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400. | Mol Cell Biol | 2012 | https://conductscience.org/library/papers/22988300 | PubMed |
| 22615493 | Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein. | Mol Cell Biol | 2012 | https://conductscience.org/library/papers/22615493 | PubMed |
| 21135874 | Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase. | Cell Res | 2011 | https://conductscience.org/library/papers/21135874 | PubMed |
| 20930110 | A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic agents. | Mol Pharmacol | 2011 | https://conductscience.org/library/papers/20930110 | PubMed |
| 20685151 | NF-κB inducing kinase: a key regulator in the immune system and in cancer. | Cytokine Growth Factor Rev | 2010 | https://conductscience.org/library/papers/20685151 | PubMed |
| 20534709 | An enigmatic tail of CD28 signaling. | Cold Spring Harb Perspect Biol | 2010 | https://conductscience.org/library/papers/20534709 | PubMed |
| 20368329 | Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20368329 | PubMed |
| 19649278 | Comparison of peptide array substrate phosphorylation of c-Raf and mitogen activated protein kinase kinase kinase 8. | PLoS One | 2009 | https://conductscience.org/library/papers/19649278 | PubMed |
| 18831712 | BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes. | Biochem J | 2009 | https://conductscience.org/library/papers/18831712 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| CHUK | 1147 | PubTator's text mining | https://conductscience.org/library/genes/1147 | NCBI Gene |
| IKBKB | 3551 | PubTator's text mining | https://conductscience.org/library/genes/3551 | NCBI Gene |
| IKBKE | 9641 | PubTator's text mining | https://conductscience.org/library/genes/9641 | NCBI Gene |
| MAP3K14 | 9020 | PubTator's text mining | https://conductscience.org/library/genes/9020 | NCBI Gene |
| MAP3K8 | 1326 | PubTator's text mining | https://conductscience.org/library/genes/1326 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10072079
GET https://conductscience.org/api/papers/v1/10072079/cited_by?page=2